Skip to content
Screener

Net Income at other companies

Biogen logo
BiogenBIIB
$97.5M-84.6%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-$49.01M-20.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.81M-100%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$120.85M-4.8%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
-$54.8M-38.8%
CalAmp logo
CalAmpCAMP
-$18.33M-47.4%

Segments

By segment

See full
Single Reportable-$109.9M+0.1%

Other financials

Income statement

See full
Revenue-
Operating income-$108.9M+2.9%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$5.74B+92.7%
Enterprise value$5.5B+90.9%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio+0.7×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Scholar Rock’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336732
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest expense(4,518)(1,206)(6,820)(3,025)
Other expense, net(570)(127)(1,360)(171)
Total other income (expense), net(995)2,078(4,489)4,445
Net loss$$(109,896)(110,031)$(215,406)$(184,754)
Net loss per share, basic and diluted$$(0.84)(0.98)$(1.67)$(1.65)
Weighted average common shares outstanding, basic and diluted130,612,734112,703,014128,954,153112,273,032
Comprehensive loss:
Net loss$$(109,896)(110,031)$(215,406)$(184,754)

Item 1. Financial Statements

FAQ

What is Scholar Rock's net income?
Scholar Rock (SRRK) reported net income of -$109.9M in Q2 2026.
How has Scholar Rock's net income changed year-over-year?
Scholar Rock's net income increased by 0.1% year-over-year, from -$110.03M to -$109.9M.
What is the long-term trend for Scholar Rock's net income?
Over 4 years (2021 to 2025), Scholar Rock's net income has grown at a 30.1% compound annual growth rate (CAGR), from -$131.8M to -$377.94M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Scholar Rock's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude